News and Press

Press releases

Kommuniké från årsstämma den 11 juni 2024 i Diagonal Bio AB

Regulatory

Idag, den 11 juni 2024, hölls årsstämma i Diagonal Bio AB. Nedan följer en sammanfattning av de beslut som fattades.

Read more

Bulletin from the Annual General Meeting on 11 June 2024 in Diagonal Bio AB

Regulatory

Today, on 11 June 2024, the Annual General Meeting of Diagonal Bio AB was held. A summary of the adopted resolutions follows below.

Read more

Diagonal Bio AB first quarter (Q1 2024)

Regulatory

“The end of last year was marked by our focus on creating the business platform to generate the company’s initial revenue in 2024. We continue and gear up on the set path with a focus on generating revenue”.

Read more

Diagonal Bio appoints new CFO

Regulatory

Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) has appointed Fata Mrsic as the new Chief Financial Officer (CFO). Fata will assume the position on June 14, 2024, and be part of the Management Team.

Read more

Diagonal Bio announces strategic pilot study with Löberöds Hästklinik

Regulatory

Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) is pleased to announce a significant new collaboration with Löberöds Hästklinik, led by renowned sporthorse veterinarian Lisa Lidbeck. The agreement, set to last an initial term of three months, will involve a pilot testing program focused on utilizing Diagonal Bio’s platform technology, LAMPlify®, for the detection of respiratory viral infections in sporthorses.

Read more